Hints and tips:
Related Special Reports
...This article has been amended to clarify details of the proposed drug trial by the NHS and Novartis...
...Steven Hadfield does not have the luxury of considering retirement....
...Squares of land owned by the public, sandwiched between squares of land owned by private individuals and corporations. And the boundaries of these squares are often invisible property lines....
...He founded and later sold the companies Pharmaceutical Product Development, a contract research organisation, and Furiex Pharmaceuticals, whose leading product was a diarrhoea medication....
...Haleon was a joint venture between GSK and Pfizer that included consumer brands acquired from Novartis....
...In 2020, when pharmaceutical manufacturers Roche and Novartis were fined €444mn for allegedly pushing their jointly marketed eye medicine Lucentis over a cheaper alternative, Thill-Tayara successfully argued...
...In 2014, Oxford-based Circassia Pharmaceuticals, an allergy specialist, launched a £581mn initial public offering, a record at the time for a London-listed biotech....
...Psilocybin was first clinically manufactured in 1959 by Sandoz, now part of Novartis, but the company had never commercialised it....
...Novartis said it did not think the decline in sales was linked to reports of deaths of two children who had taken the drug....
...This will leave the vaccines and pharmaceuticals divisions more exposed to investor scrutiny but will also give the company a windfall of about £7bn to invest in its drug pipeline....
...At Swiss pharmaceutical company Novartis, suppliers — which range from producers of ingredients, materials and finished goods to transport and real estate businesses — generate just over 90 per cent of its...
...In the canton of Basel-Stadt for example, home to 201,000 residents as well as the pharmaceutical companies Roche and Novartis, 20 per cent of government revenues — about CHF600m annually — come from corporation...
...When Shannon Thyme Klinger left the top legal job at Swiss pharmaceutical group Novartis to join US biotech Moderna this month, she was motivated by a deep sense of purpose — professional and personal....
...The deal settles civil allegations against its US arm, Novartis Pharmaceuticals Corporation, and is the company’s third big resolution with US authorities in recent months....
...This is a guest post by Steven Desmyter, Man Group’s co-head of responsible investing who argues that when it comes to the Covid-19 vaccine, it pays not to profit from disaster....
...Outgoing Treasury secretary Steven Mnuchin refused to extend five programmes beyond their December 31 expiration date, despite pleas from investors....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...(FT) Vaccine developers to be questioned Executives from five pharmaceutical companies at the forefront of work to develop a coronavirus vaccine will be questioned by US lawmakers today....
...We should also treat the Big Tech companies as regular corporations that should be subject to regulation just as previous oligopolists were....
...The Big Three are on course to control 40 per cent of the votes in American corporations in a couple of decades....
...The company also said on Thursday that Steven Meyer, chair of the board, and Pierre Lapalme, another board member, would resign after the settlement....
...“Car-T therapy is a true game changer, and NHS cancer patients are now going to be amongst the first in the world to benefit,” said Simon Stevens, chief executive of NHS England....
...“Investors often pre-empt index changes, but for the first time they are underweight China A shares,” said Steven Holden, founder of Copley Fund Research....
...Large, venerable corporations can struggle to see what lies ahead for their industry. Consider Novartis....
...The earnings calendar also features industrial heavyweights Boeing, Caterpillar, Lockheed Martin and Honeywell; energy groups Exxon Mobil, Chevron and Royal Dutch Shell; and pharmaceutical companies Novartis...
International Edition